Deutsche Bank Anticipates Strong MDRX Results, Attractive Entry Point Post Recent Sell-Off

Deutsche Bank reports that it expects strong results from Allscripts Healthcare Solutions, Inc.

, a stock that it says has an “attractive entry point post recent sell-off.” “We view MDRX as well-positioned to deliver solid results in the quarter,” Deutsche Bank writes. “We view contribution from recent strong bookings, continued new bookings momentum, and further progress on the company's synergy capture plans all leading towards strong EPS growth. “The stock came under pressure over the last week following the announced resignation of CTO John Gomez, and we view that sell-off as overdone.” Allscripts Healthcare Solutions closed Wednesday at $20.45.